BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue (NYSE:TBI) but lowers the price target from $13 to $12.
August 07, 2024 | 3:16 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue but lowers the price target from $13 to $12.
The Outperform rating suggests continued confidence in TrueBlue's performance, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100